TSC is a rare, multi-system genetic disease that can cause benign tumours to grow on the brain or other vital organs such as the kidneys, heart, eyes, lungs, and skin.
A combination of symptoms may include seizures, developmental delay, behavioural problems and skin abnormalities, as well as lung and kidney disease.
[1] Originally regarded as a rare pathological curiosity, it is now an important focus of research into tumour formation and suppression.
[2] In the late 19th century, notable physicians working in European teaching hospitals first described the cortical and dermatological manifestations; these early researchers have been awarded with eponyms such as "Bourneville's disease"[3] and "Pringle's adenoma sebaceum".
2012 A consensus conference was held and revised guidelines for the diagnosis and management of tuberous sclerosis were published.